Not applicableNo Longer AvailableNCT04518644What this trial is testingNilotinib, for Patients With CML-CP or CML-APWho this might be right forChronic Myelogenous Leukemia (CML) Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT00004009What this trial is testingR115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaWho this might be right forLeukemia University of Maryland, Baltimore
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Testing effectiveness (Phase 2)Ended earlyNCT00005984What this trial is testingCyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous LeukemiaWho this might be right forLeukemia Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT03886831What this trial is testingPRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesWho this might be right forRelapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more Prelude Therapeutics Incorporated 232
Early research (Phase 1)Study completedNCT00017472What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid LeukemiaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNoncontiguous Stage II Marginal Zone Lymphoma+11 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT01773395What this trial is testingGVAX vs. Placebo for MDS/AML After Allo HSCTWho this might be right forMyelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia Dana-Farber Cancer Institute 123
Early research (Phase 1)WithdrawnNCT03807063What this trial is testingRivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWho this might be right forAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00049465What this trial is testingStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more Fred Hutchinson Cancer Center 150
Large-scale testing (Phase 3)Ended earlyNCT01827930What this trial is testingPhase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular ResponseWho this might be right forLeukemia, Myeloid, Chronic-Phase Institut Bergonié 68
Testing effectiveness (Phase 2)WithdrawnNCT01011998What this trial is testingImatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)Who this might be right forChronic Myelogenous Leukemia New Mexico Cancer Research Alliance
Early research (Phase 1)Study completedNCT05665530What this trial is testingPRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic MalignanciesWho this might be right forAggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)+9 more Prelude Therapeutics Incorporated 86
Early research (Phase 1)Study completedNCT00710528What this trial is testingDose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic MalignanciesWho this might be right forChronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)+1 more Gilead Sciences 192
Early research (Phase 1)Study completedNCT00351975What this trial is testingBelinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesWho this might be right forAccelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more National Cancer Institute (NCI) 56
Early research (Phase 1)Active Not RecruitingNCT04603001What this trial is testingStudy of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 MutationsWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more Eli Lilly and Company 260
Large-scale testing (Phase 3)Ended earlyNCT04266301What this trial is testingStudy of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)Who this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic Novartis Pharmaceuticals 530
Early research (Phase 1)Ended earlyNCT00800150What this trial is testingTotal Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more City of Hope Medical Center 6
Testing effectiveness (Phase 2)Ended earlyNCT03246906What this trial is testingComparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT00098033What this trial is testingInvestigation of Clofarabine in Acute LeukemiasWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia University of Texas 64